FDA officials argue over safety of new arthritis drug.

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'FDA officials argue over safety of new arthritis drug.'. Together they form a unique fingerprint.

Medicine & Life Sciences